Could Nu Skin Enterprises, Inc. (NUS) Go Down After Reaching 52-Week High?

May 17, 2018 - By Alfred Lee

Nu Skin Enterprises, Inc. (NYSE:NUS) Logo

Investors sentiment increased to 1.16 in Q4 2017. Its up 0.09, from 1.07 in 2017Q3. It is positive, as 19 investors sold Nu Skin Enterprises, Inc. shares while 75 reduced holdings. 42 funds opened positions while 67 raised stakes. 37.52 million shares or 2.40% less from 38.44 million shares in 2017Q3 were reported.
Dekabank Deutsche Girozentrale owns 6,938 shares. State Common Retirement Fund invested in 0.02% or 198,987 shares. Glob X Ltd Limited Liability Company invested 0% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS). State Of Alaska Department Of Revenue owns 3,600 shares or 0.01% of their US portfolio. Crawford Invest Counsel has 0.12% invested in Nu Skin Enterprises, Inc. (NYSE:NUS). Point72 Asset Limited Partnership invested in 0% or 1,173 shares. Goldman Sachs Group Inc holds 0.02% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS) for 1.38M shares. Jefferies Grp Ltd Liability holds 4,131 shares. Solaris Asset Mgmt Limited Company has 1,725 shares. California-based Franklin Resources Inc has invested 0% in Nu Skin Enterprises, Inc. (NYSE:NUS). Teacher Retirement Sys Of Texas holds 18,254 shares. Winfield Associates accumulated 0% or 20 shares. Gideon Advsrs, a New York-based fund reported 5,088 shares. California State Teachers Retirement holds 0.01% or 87,738 shares in its portfolio. Quantbot Techs Lp reported 527 shares stake.

Since January 19, 2018, it had 0 insider purchases, and 10 insider sales for $118.14 million activity. Another trade for 724 shares valued at $52,751 was sold by Lawrence Mark H. LUND STEVEN had sold 81,000 shares worth $6.08M. On Wednesday, March 7 the insider Ping An ZQ China Growth Opportunity Ltd sold $107.49 million. Thomas Pisano R. sold $1.08 million worth of stock.

The stock of Nu Skin Enterprises, Inc. (NYSE:NUS) hit a new 52-week high and has $85.48 target or 8.00 % above today’s $79.15 share price. The 9 months bullish chart indicates low risk for the $4.40 billion company. The 1-year high was reported on May, 17 by If the $85.48 price target is reached, the company will be worth $352.16M more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock.

The stock increased 0.16% or $0.13 during the last trading session, reaching $79.15. About 216,320 shares traded. Nu Skin Enterprises, Inc. (NYSE:NUS) has risen 33.34% since May 17, 2017 and is uptrending. It has outperformed by 21.79% the S&P500.

Analysts await Nu Skin Enterprises, Inc. (NYSE:NUS) to report earnings on August, 1. They expect $0.89 earnings per share, up 15.58 % or $0.12 from last year’s $0.77 per share. NUS’s profit will be $49.50M for 22.23 P/E if the $0.89 EPS becomes a reality. After $0.64 actual earnings per share reported by Nu Skin Enterprises, Inc. for the previous quarter, Wall Street now forecasts 39.06 % EPS growth.

Nu Skin Enterprises, Inc. (NYSE:NUS) Ratings Coverage

Among 3 analysts covering Nu Skin (NYSE:NUS), 1 have Buy rating, 1 Sell and 1 Hold. Therefore 33% are positive. Nu Skin had 5 analyst reports since January 23, 2018 according to SRatingsIntel. Stifel Nicolaus maintained Nu Skin Enterprises, Inc. (NYSE:NUS) rating on Thursday, February 15. Stifel Nicolaus has “Sell” rating and $57.0 target. Deutsche Bank maintained the shares of NUS in report on Friday, February 16 with “Buy” rating. Deutsche Bank downgraded Nu Skin Enterprises, Inc. (NYSE:NUS) on Friday, April 13 to “Hold” rating. As per Monday, April 30, the company rating was maintained by Citigroup.

Another recent and important Nu Skin Enterprises, Inc. (NYSE:NUS) news was published by which published an article titled: “Analysis: Positioning to Benefit within United Natural Foods, Capitol Federal Financial, Royal Gold, Celsion, National …” on May 15, 2018.

Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. The company has market cap of $4.40 billion. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC Transformation anti-aging skin care systems; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. It has a 33.54 P/E ratio. The firm also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products.

Nu Skin Enterprises, Inc. (NYSE:NUS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: